# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Ryan Macwilliams maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $80 to $70.
Piper Sandler analyst Brent Bracelin maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $55 to...
Scotiabank analyst Nick Altmann upgrades Braze (NASDAQ:BRZE) from Sector Perform to Sector Outperform and raises the price t...
Needham analyst Scott Berg reiterates Braze (NASDAQ:BRZE) with a Buy and maintains $70 price target.
Oppenheimer analyst Brian Schwartz maintains Braze (NASDAQ:BRZE) with a Outperform and maintains $60 price target.
Needham analyst Scott Berg reiterates Braze (NASDAQ:BRZE) with a Buy and maintains $70 price target.